Synthesis and photochemical switching of the antiferroelectric liquid crystals containing a diazenediyl group

DOI: 10.1246/cl.1996.583

Source and publish data:

Chemistry Letters p. 583 - 584 (1996)

Update date:2022-09-26

Topics:

Authors:

Negishi, Makoto

Kanie, Kiyoshi

Ikeda, Tomiki

Hiyama, Tamejiro

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1246/cl.1996.583

Photochromic antiferroelectric liquid crystals containing a diazene moiety were synthesized for the first time, and their photochemical switching behaviors were studied.

Full text of DOI:10.1246/cl.1996.583

Products guided by the article

Product name:4-Methoxycarbonyloxy-benzoic acid (S)-1-trifluoromethyl-heptyl ester

Cas No:200562-69-2

R&D Labs maybe for 200562-69-2

Hangzhou Eastbiopharm Co.,Ltd.

Contact:+86-571-88931780

Address:Hangzhou,China
Clearsynth Labs Limited

Contact:+91 - 22 - 26355700

Address:17, Lotus Business Park, Andheri West
Zhejiang Chemline International Co., Ltd.

Contact:+86-571-88062298

Address:Hengdian Industry Area, Dongyang, Zhejiang, China
Jitat Company Ltd

Contact:852-27701081

Address:Room 2509, New Tech Plaza, 34 Tai Yau St., San Po Kong, HK
Changsha Nutritopper Bio Technology Co.,Ltd.

Contact:+86-731-87803543

Address:East 1st Street, Baima Road, Ningxiang County

Relevant to this article

Doi:10.1021/ja01020a037
(1968)
Preparation, characterization, and X-ray structure of the 1:1 complex of o-acetylstyrene and carbonylbis(triphenylphosphine)ruthenium. A new catalyst for the copolymerization of acetophenone and 1,3-divinyltetramethyldisiloxane

Doi:10.1021/om9708541
(1998)
Doi:10.1021/jo01261a053
(1969)
²H NMR Evidence for dynamic disorder in human skin induced by the penetration enhancer Azone

Doi:10.1016/0584-8539(96)01680-7
(1996)
Tricyclic heteroaromatic systems. Pyrazolo[3,4-c]quinolin-4-ones and pyrazolo[3,4-c]quinoline-1,4-diones: Synthesis and benzodiazepine receptor activity

Doi:10.1002/ardp.19973301205
(1997)
Therapeutic evaluation of synthetic peucedanocoumarin III in an animal model of Parkinson’s disease

Doi:10.3390/ijms20215481
(2019)

Article Doi